We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · June 16, 2021

ASCO 2021: MonarchE Subanalysis Showed Benefits of Abemaciclib Extend to Patients With High-Risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy

Benefits were similar to those observed in the overall intent-to-treat population

PracticeUpdate Editorial Team

 

Further Reading